The Validation of the CAP-PRI (Chronic Acquired Polyneuropathy-Patient Reported Index) in Patients with Acquired and Idiopathic Polyneuropathy
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 16-000125
Sponsor Protocol Number: 16-000125
About this study
The primary objective of this study is to validate the chronic acquired polyneuropathy-patient reported index (CAP-PRI) in subjects with acquired and idiopathic polyneuropathy.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Diagnosis of acquired polyneuropathy (diabetic neuropathy, chemotherapy-related neuropathy, alcohol-related neuropathy, vitamin-deficient neuropathy, immune-mediated neuropathies (CIDP, DADS, MMN, Guillain-Barre Syndrome (GBS), systemic vasculitic neuropathy (SVN), nonsystemic vasculitic neuropathy (NSVN), sicca-associated neuropathy, paraneoplastic neuropathy, and other CIP), or idiopathic painful and idiopathic painless neuropathy)
- 18 years or older
- English-speaking
- Pregnant and breastfeeding women may be enrolled
Exclusion Criteria:
- Subjects who do not meet the diagnostic criteria
- Non English Speakers
- Prisoners
- Patients who are unable to read and write
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Michelle Mauermann, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available